BIMI OTC
BIMI International Medical Inc.
1W: -50.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
3Y: -99.9%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Weekly Expected Move ±206.4%
$-0
$-0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$12M
-44.5% ▼
5Y CAGR: +6.8%
Gross Profit
$2M
-19.6% ▼
5Y CAGR: +16.3%
Operating Income
-$15M
-89.2% ▼
Net Income
-$22M
+36.0% ▲
EPS (Diluted)
$-8.40
+87.1% ▲
EBITDA
-$18M
+43.8% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|
| Revenue | $7M | $158K | $13M | $21M | $12M |
| YoY Growth | -23.1% | -97.6% | +8030.9% | +66.0% | -44.5% |
| Cost of Revenue | $6M | $304K | $10M | $19M | $10M |
| Gross Profit | $459K | -$146K | $2M | $2M | $2M |
| Gross Margin | 7.0% | -92.4% | 19.0% | 11.4% | 16.5% |
| R&D Expenses | $56K | $0 | $0 | $0 | $0 |
| SG&A Expenses | $16M | $986K | $6M | $8M | $12M |
| Operating Expenses | $16M | $2M | $6M | $8M | $17M |
| Operating Income | -$16M | -$986K | -$4M | -$8M | -$15M |
| Operating Margin | -241.4% | -624.1% | -29.7% | -38.0% | -129.7% |
| Interest Expense | $416K | $6K | $85K | $2M | $3M |
| Income Before Tax | -$17M | -$2M | -$3M | -$35M | -$22M |
| Tax Expense | $117 | $0 | $434K | $30K | $6K |
| Net Income | -$17M | -$4M | -$5M | -$35M | -$22M |
| Net Margin | -256.6% | -2809.9% | -41.2% | -164.1% | -189.3% |
| EPS (Diluted) | $-112.25 | $-27.50 | $-24.80 | $-65.10 | $-8.40 |
| EBITDA | -$16M | -$1M | -$3M | -$32M | -$18M |
| Shares Outstanding | 149547 | 163383 | 213456 | 536293 | 3M |